Respiratory syncytial virus (RSV) is a leading cause for global infant morbidity and mortality. The COVID-19 pandemic caused significant shifts in seasonality of RSV, and changes in disease severity have been matter of intense discussion. Between September 2020 and February 2023, the multicentric, prospective PAPI study analyzed rates and phenotypes of hospitalized RSV patients aged
- Bähre, J.
- Lange, M.
- Salaschek, P.
- Twardella, D.
- Arens, S.
- Eberhard, F.
- Barten-Neiner, G.
- Panning, M.
- Köster, H.
- Körner-Rettberg, C.
- Wetzke, M.
- Happle, C.
Keywords
- Humans
- *Respiratory Syncytial Virus Infections/epidemiology
- *COVID-19/epidemiology
- *Seasons
- Infant
- Male
- Female
- Prospective Studies
- Germany/epidemiology
- *Respiratory Insufficiency/epidemiology/etiology
- Hospitalization/statistics & numerical data
- Infant, Newborn
- Retrospective Studies
- SARS-CoV-2
- Covid-19
- Pandemic
- Rsv
- Resurgence
- Seasonality